Nama Insights

Virtus LifeSci Biotech Products ETF (BBP)

Health · Virtus · NYSE

HealthETF
Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund in the Health category. It has $86.78M in assets, an expense ratio of 0.34% and a 0.00% dividend yield. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.
Assets under management$86.78M
Expense ratio0.34%
CategoryHealth
Dividend yield0.00%
NAV$94.11
Fund familyVirtus
ExchangeNYSE

Top holdings

The largest positions Virtus LifeSci Biotech Products ETF reports, by weight.

HoldingNameWeight
MRNA Moderna Inc 1.88%
RARE Ultragenyx Pharmaceutical Inc 1.84%
PGEN Precigen Inc 1.72%
AGIO Agios Pharmaceuticals Inc 1.69%
RYTM Rhythm Pharmaceuticals Inc 1.68%
LGND Ligand Pharmaceuticals Inc 1.66%
IBRX ImmunityBio Inc Ordinary Shares 1.65%
KNSA Kiniksa Pharmaceuticals International PLC Class A 1.65%
ASND Ascendis Pharma AS 1.64%
CYTK Cytokinetics Inc 1.63%

Other Health ETFs

Explore live BBP data on Nama Insights →